Troponin Market - Size and Forecast [2021-2031]
The Troponin Market is expected to register a CAGR of 8.10% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report presents an analysis based on by type (troponin t, troponin i). The report is segmented by applicaiton (acute coronary syndrome, myocardial infraction, congestive heart failure, others). The report further provides analysis based on end user (hospital, diagnostic center, homecare setting). The global analysis is further broken-down at regional level and major countries. The market size and forecast at global, regional, and country levels for all the key market segments are covered under the scope. The report offers the value in USD for the above analysis and segments. The report provides key statistics on the market status of the key market players and offers market trends and opportunities.
Purpose of the ReportThe report Troponin Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Troponin Market Segmentation
Type- Troponin T
- Troponin I
- Acute Coronary Syndrome
- Myocardial Infraction
- Congestive Heart Failure
- Others;
- Hospital
- Diagnostic Center
- Homecare Setting
Strategic Insights
Troponin Market Growth Drivers- Rising Prevalence of Cardiovascular Diseases:Increasing incidence of cardiovascular diseases such as heart attacks and heart failure is an important factor for the growth of the troponin market. Troponin is a major biomarker to diagnose cardiac injury; thus, the demand for the biomarker will increase to detect and monitor heart-related conditions in a better and more accurate way.
- Advancements in Diagnostic Technologies:Technological advances in point-of-care testing and rapid diagnostic tools complement the troponin market. They are so new that they allow change to be completed faster and set in more accurate machines, making a speedier diagnosis of acute myocardial infarction (AMI)—improvements in terms of outcome for patients in critical care environments.
- Improved Clinical Guidelines and Adoption: Adoption of more precise clinical guidelines to use troponin tests for the diagnosis and management of heart attacks has spurred market growth. Providers of healthcare are incorporating the troponin testing within their clinical protocols to ensure timely and accurate diagnosis enhancing standards of care with respect to heart patients.
- Troponin Testing at Home:A key emerging trend in health care is home-based interventions, and this has resulted in development of these portable and easy-to-use test kits for measuring troponin at home. Patients will therefore not find it difficult to test their hearts while at home. It becomes cheap and easy to do testing, especially in chronic cardiovascular disease patients, as they require continuous monitoring.
- Assessment of Personalized Cardiovascular Risk:The rising trend of personalized medicine has roped in troponin testing along with genomic data and lifestyle data to make an individual's cardiovascular risk assessment. Such trend advancements hasten towards customizing treatment plans against good outcome interventions and stimulating demand for adding troponin testing into greater risk management strategies.
- Integration of Troponin with Other Biomarkers:A new important trend is combining troponin testing with other biomarkers, like BNP or CRP. Combining different biomarkers for studying heart health offers a more holistic image of heart health, increases precision in diagnosis, and enhances clinical decision making for better management of cardiac care.
- Point-of-Care Device Development: Point-of-care troponin testing products can be manufactured for manufacturers to cash in on the needs of rapid diagnostic solutions. Such testing devices enable healthcare providers to make faster decisions to reduce heart attack diagnosis wait times and improve patient outcomes, especially in emergency venues like ambulances and clinics.
- Emerging Markets Boom: Troponin producers have great leeway to expand their territories in emerging economies. As improving healthcare infrastructure further permeates more areas such as the Asia-Pacific and Africa region, it will continue to increase the demand for accurate and inexpensive troponin testing devices and bring chances to grow for the manufacturers in such regions.
- Advances in Digital and Remote Monitoring:Manufacturers can capitalize opportunities in digital health by creating connected troponin testing platforms. Remote monitoring of troponin levels, especially in patients with chronic heart conditions, could improve patient care. Providing digital solutions that allow real-time tracking of troponin levels can enhance adherence to treatment plans and improve long-term outcomes.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Troponin Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Troponin Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The troponin market is estimated to grow with a CAGR of 8.2% from 2023 to 2031
sia Pacific region is likely to witness fastest growth rate during the forecast period
The troponin market majorly consists of the players such as 3M, PLANMECA OY, Dentsply Sirona among others
Development of digital dentistry products likely to remain the key trend during the forecast period
The market drivers include rising prevalence of dental disorders and increasing awareness for oral health are driving the troponin market
North America dominated the troponin market in 2023
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Troponin Market - By Type
1.3.2 Troponin Market - By Applicaiton
1.3.3 Troponin Market - By End User
1.3.4 Troponin Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TROPONIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TROPONIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TROPONIN MARKET - GLOBAL MARKET ANALYSIS
6.1. TROPONIN - GLOBAL MARKET OVERVIEW
6.2. TROPONIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. TROPONIN MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TROPONIN T
7.3.1. Overview
7.3.2. Troponin T Market Forecast and Analysis
7.4. TROPONIN I
7.4.1. Overview
7.4.2. Troponin I Market Forecast and Analysis
8. TROPONIN MARKET - REVENUE AND FORECASTS TO 2028 - APPLICAITON
8.1. OVERVIEW
8.2. APPLICAITON MARKET FORECASTS AND ANALYSIS
8.3. ACUTE CORONARY SYNDROME
8.3.1. Overview
8.3.2. Acute Coronary Syndrome Market Forecast and Analysis
8.4. MYOCARDIAL INFRACTION
8.4.1. Overview
8.4.2. Myocardial Infraction Market Forecast and Analysis
8.5. CONGESTIVE HEART FAILURE
8.5.1. Overview
8.5.2. Congestive Heart Failure Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. TROPONIN MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL
9.3.1. Overview
9.3.2. Hospital Market Forecast and Analysis
9.4. DIAGNOSTIC CENTER
9.4.1. Overview
9.4.2. Diagnostic Center Market Forecast and Analysis
9.5. HOMECARE SETTING
9.5.1. Overview
9.5.2. Homecare Setting Market Forecast and Analysis
10. TROPONIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Troponin Market Overview
10.1.2 North America Troponin Market Forecasts and Analysis
10.1.3 North America Troponin Market Forecasts and Analysis - By Type
10.1.4 North America Troponin Market Forecasts and Analysis - By Applicaiton
10.1.5 North America Troponin Market Forecasts and Analysis - By End User
10.1.6 North America Troponin Market Forecasts and Analysis - By Countries
10.1.6.1 United States Troponin Market
10.1.6.1.1 United States Troponin Market by Type
10.1.6.1.2 United States Troponin Market by Applicaiton
10.1.6.1.3 United States Troponin Market by End User
10.1.6.2 Canada Troponin Market
10.1.6.2.1 Canada Troponin Market by Type
10.1.6.2.2 Canada Troponin Market by Applicaiton
10.1.6.2.3 Canada Troponin Market by End User
10.1.6.3 Mexico Troponin Market
10.1.6.3.1 Mexico Troponin Market by Type
10.1.6.3.2 Mexico Troponin Market by Applicaiton
10.1.6.3.3 Mexico Troponin Market by End User
10.2. EUROPE
10.2.1 Europe Troponin Market Overview
10.2.2 Europe Troponin Market Forecasts and Analysis
10.2.3 Europe Troponin Market Forecasts and Analysis - By Type
10.2.4 Europe Troponin Market Forecasts and Analysis - By Applicaiton
10.2.5 Europe Troponin Market Forecasts and Analysis - By End User
10.2.6 Europe Troponin Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Troponin Market
10.2.6.1.1 Germany Troponin Market by Type
10.2.6.1.2 Germany Troponin Market by Applicaiton
10.2.6.1.3 Germany Troponin Market by End User
10.2.6.2 France Troponin Market
10.2.6.2.1 France Troponin Market by Type
10.2.6.2.2 France Troponin Market by Applicaiton
10.2.6.2.3 France Troponin Market by End User
10.2.6.3 Italy Troponin Market
10.2.6.3.1 Italy Troponin Market by Type
10.2.6.3.2 Italy Troponin Market by Applicaiton
10.2.6.3.3 Italy Troponin Market by End User
10.2.6.4 Spain Troponin Market
10.2.6.4.1 Spain Troponin Market by Type
10.2.6.4.2 Spain Troponin Market by Applicaiton
10.2.6.4.3 Spain Troponin Market by End User
10.2.6.5 United Kingdom Troponin Market
10.2.6.5.1 United Kingdom Troponin Market by Type
10.2.6.5.2 United Kingdom Troponin Market by Applicaiton
10.2.6.5.3 United Kingdom Troponin Market by End User
10.2.6.6 Rest of Europe Troponin Market
10.2.6.6.1 Rest of Europe Troponin Market by Type
10.2.6.6.2 Rest of Europe Troponin Market by Applicaiton
10.2.6.6.3 Rest of Europe Troponin Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Troponin Market Overview
10.3.2 Asia-Pacific Troponin Market Forecasts and Analysis
10.3.3 Asia-Pacific Troponin Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Troponin Market Forecasts and Analysis - By Applicaiton
10.3.5 Asia-Pacific Troponin Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Troponin Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Troponin Market
10.3.6.1.1 Australia Troponin Market by Type
10.3.6.1.2 Australia Troponin Market by Applicaiton
10.3.6.1.3 Australia Troponin Market by End User
10.3.6.2 China Troponin Market
10.3.6.2.1 China Troponin Market by Type
10.3.6.2.2 China Troponin Market by Applicaiton
10.3.6.2.3 China Troponin Market by End User
10.3.6.3 India Troponin Market
10.3.6.3.1 India Troponin Market by Type
10.3.6.3.2 India Troponin Market by Applicaiton
10.3.6.3.3 India Troponin Market by End User
10.3.6.4 Japan Troponin Market
10.3.6.4.1 Japan Troponin Market by Type
10.3.6.4.2 Japan Troponin Market by Applicaiton
10.3.6.4.3 Japan Troponin Market by End User
10.3.6.5 South Korea Troponin Market
10.3.6.5.1 South Korea Troponin Market by Type
10.3.6.5.2 South Korea Troponin Market by Applicaiton
10.3.6.5.3 South Korea Troponin Market by End User
10.3.6.6 Rest of Asia-Pacific Troponin Market
10.3.6.6.1 Rest of Asia-Pacific Troponin Market by Type
10.3.6.6.2 Rest of Asia-Pacific Troponin Market by Applicaiton
10.3.6.6.3 Rest of Asia-Pacific Troponin Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Troponin Market Overview
10.4.2 Middle East and Africa Troponin Market Forecasts and Analysis
10.4.3 Middle East and Africa Troponin Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Troponin Market Forecasts and Analysis - By Applicaiton
10.4.5 Middle East and Africa Troponin Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Troponin Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Troponin Market
10.4.6.1.1 South Africa Troponin Market by Type
10.4.6.1.2 South Africa Troponin Market by Applicaiton
10.4.6.1.3 South Africa Troponin Market by End User
10.4.6.2 Saudi Arabia Troponin Market
10.4.6.2.1 Saudi Arabia Troponin Market by Type
10.4.6.2.2 Saudi Arabia Troponin Market by Applicaiton
10.4.6.2.3 Saudi Arabia Troponin Market by End User
10.4.6.3 U.A.E Troponin Market
10.4.6.3.1 U.A.E Troponin Market by Type
10.4.6.3.2 U.A.E Troponin Market by Applicaiton
10.4.6.3.3 U.A.E Troponin Market by End User
10.4.6.4 Rest of Middle East and Africa Troponin Market
10.4.6.4.1 Rest of Middle East and Africa Troponin Market by Type
10.4.6.4.2 Rest of Middle East and Africa Troponin Market by Applicaiton
10.4.6.4.3 Rest of Middle East and Africa Troponin Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Troponin Market Overview
10.5.2 South and Central America Troponin Market Forecasts and Analysis
10.5.3 South and Central America Troponin Market Forecasts and Analysis - By Type
10.5.4 South and Central America Troponin Market Forecasts and Analysis - By Applicaiton
10.5.5 South and Central America Troponin Market Forecasts and Analysis - By End User
10.5.6 South and Central America Troponin Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Troponin Market
10.5.6.1.1 Brazil Troponin Market by Type
10.5.6.1.2 Brazil Troponin Market by Applicaiton
10.5.6.1.3 Brazil Troponin Market by End User
10.5.6.2 Argentina Troponin Market
10.5.6.2.1 Argentina Troponin Market by Type
10.5.6.2.2 Argentina Troponin Market by Applicaiton
10.5.6.2.3 Argentina Troponin Market by End User
10.5.6.3 Rest of South and Central America Troponin Market
10.5.6.3.1 Rest of South and Central America Troponin Market by Type
10.5.6.3.2 Rest of South and Central America Troponin Market by Applicaiton
10.5.6.3.3 Rest of South and Central America Troponin Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. TROPONIN MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SIEMENS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. LSI MEDICINE CORPORATION
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. EUROLYSER DIAGNOSTICA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. TULIP DIAGNOSTIC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. RESPONSE BIOMEDICAL CORP
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1.Abbott
2.Siemens
3.LSI Medicine Corporation
4.Eurolyser Diagnostica
5.Tulip Diagnostic
6.Response Biomedical Corp
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For